Azelis lands nitroalkanes distribution deal with Angus Chemical

By Gareth Macdonald

- Last updated on GMT

istock/nitroalkanes
istock/nitroalkanes
Angus Chemical Company has hired Azelis to distribute its nitroalkanes to pharmaceutical and biotech companies in Europe.

The deal – terms of which were not disclosed – will see Antwerp, Belgium-based Azelis ship nitroalkanes and derivatives to drug firms.

Matthew Dickman, Azelis’ Market Segment Director Pharm, explained that the agreement has provisions to allow both companies to provide technical support. 

The partnership will enable both parties to focus on providing the highest level of technical, logistical and customer service support to the growing customer base across Europe and Turkey​.”

Azelis will also supply industrial coatings companies on Angus’ behalf.

Pharma reach

Azelis employs more than 1,100 staff at sites worldwide, 70% of whom are involved in “customer facing” sales roles.

The firm's pharmaceutical business has seen a number of expansions in recent years. In November 2015 when it opened a laboratory in Hertford, UK.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars